Highlights EPCCS 2011

EPCCS 2011 Full report

The 4th Annual Scientific meeting of the EPCCS was held on September 1-2, 2011 in Berlin, Germany
Professor Arno Hoes, Utrecht, the Netherlands and  Professor Richard Hobbs, Oxford University, United Kingdom,  co-chairman of 4th annual meeting of the the European Primary Care Cardiovascular Society (EPCCS), offered a warm welcome to over 400 delegates from across Europe.

See here a full coverage of the conference for primary care professionals Read more...
 
EPCCS Annual Meetings As a service of the EPCCS in this section an overview of the presentations and meeting highlghts form our annual scientific meetings are posted.

 
EPCCS 2010

EPCCS Annual scientific Meeting 2010

In this section key educational resources derived from 3rd Annual scientific meeting held on September 23-24 2010 in Lisbon are posted.



Controversies in heart failure diagnosis

Heart failure occurs when the ventricles have a reduced ability to fill or to eject blood, resulting in an insufficient cardiac output to satisfy the metabolic needs of the body. There is a common perception that heart failure is a disease of the elderly, which has a slow onset in primary care and is always left sided. Read more...

Lifetime CV risk

Prof. Deanfield and prof. Hobbs discuss the shift in focus from treating patients with clinical problems arising from established CV disease to CV prevention in patients with risk factors for developing CV disease.

Hobbs' overview of EPCCS 2011

Prof. Richard Hobbs gives an overview of highlights from EPCCS 2011, with a summary of sessions that were held, e.g. concerning lifetime cardiovascular risk, hypertension, diabetes, and chronic kidney disease.

Update on hypertension

Prof. Richard McManus discusses the shift in diagnosis of hypertension from clinic measurement to ambulatory and home measurement.

Early recognition and treatment of TIA

Prof. Pierre Amarenco discusses the importance of early recognition and treatment of TIAs to ensure a better prognosis.

What's new in diabetes?

Dr. Neil Munro discusses several new developments in diabetes relevant for primary care.

Controversies in HF diagnosis

Dr. Frans Rutten clarifies which symptoms are suspicious for heart failure and which tests can be used .

HF Management & Monitoring

Prof. Martin R. Cowie
Good HF management does require a team approach. A nurse-led multidisciplinary programme could be of added value to patients.

Update on HF Management

Prof. Martin R. Cowie, Imperial College, London, United Kingdom
There have been two very important randomized trials in the field of heart failure in the past 12 months, which should have an impact in everybody’s practice.

My top ten studies in primary care

Prof. Martin Scherer summarizes his favourite publications of primary care studies.

The future of lipid management in stroke

Prof. Pierre Amarenco (Paris, France) describes how stroke can be prevented with statins and which patients already having stroke should receive statins.

Problems with oral anticoagulants in clinical practice

Dr. Fokko de Haan (Germany) discusses daily problems with the new oral anticoagulants.

Do biomarkers have a role in CVD prediction or follow-up?

Prof. Arno Hoes (Utrecht, The Netherlands) discusses new biomarkers for predicting of future cardiovascular disease being developed in recent years .

What do GPs need to know about this new CVD epidemic

Prof. Richard McManus (Birmingham, United Kingdom) explains what CKD is and how it should be treated, from the GP viewpoint.

Optimising Lipid Management in Stable Disease

Optimising Lipid Management in Stable Disease Prof. Furio Colivicchi (San Filippo Neri Hospital Rome, Italy)

New oral anticoagulants for venous thromboembolism

New oral anticoagulants for venous thromboembolism Prof. Henri Bounameaux (Geneva, Switzerland)
© 2011 Medcon International/EPCCS